AnteoTech Ltd (ASX: ADO) Share Price and News

Dr Cumming has over 20 years of experience in the healthcare and biotechnology market. His roles have progressed from pure research to sales and marketing roles through to Managing Director level and on the Board. Previously Managing Director of Roche Diagnostic Systems - Oceania Regional Centre, where he transformed a loss-making business to one achieving over 30% compound annual growth over a four-year period and the profitability levels in Roche's global organisation. He was also Managing Director and CEO of Biosceptre Ltd, an Australian-based biotechnology company commercialising a range of products in cancer diagnosis and treatment. He is member of the Risk Committee and Clinical Advisory Board.

Ms McLoughlin has commercial experience as a senior investment banker, commercial advisor and founder. She has over 20 years of experience on listed company boards. In her executive career she held senior executive roles at leading financial institutions Morgan Stanley, Credit Suisse and Barclays Capital where she led the Energy and Infrastructure Group in Australia. In addition to her work in the energy sector, Glenda has experience in the medical diagnostics, telecommunications, information technology, media, transport and financial services sectors. She is also Chair of the Risk Committee.

Mr Martin holds a Bachelor of Business. He practised as a Chartered Accountant for 16 years, 11 as a partner in a medium sized Sydney practice. Mr Martin has been involved with the Company since it was founded by Dr Maeji. He has considerable experience both operationally and advising corporate entities, his work has included complex business structuring and financing, the establishment of international hotels from conception, public listing of companies, management of foreign currency exposure, establishing and operating start up technology companies and the negotiation and implementation on the purchase and sale of enterprises.

Ms Gray is an executive and Board member, with a 30-year career spanning a range of critical minerals, renewables and energy industry businesses. Ms Gray brings experience from the European Union and specifically with German automotive Original Equipment Manufacturers (OEMs) and the management of their battery materials supply chains. Ms Gray has held a range of executive business and technology development roles in Australia and globally, and is currently a corporate advisor in energy transitioning/decarbonisation working with multi-nationals as well as new and emerging technology companies. Her executive career has included accessing and developing new markets in Lithium-ion Battery (LiB) cathode and anode production, LiB recycling, large scale renewable energy and storage project development as well as establishing synfuels and waste to energy businesses. Ms Gray was Head of Recycling at Neometals (ASX: NMT) and Co-Managing Director of Primobius GmbH post COVID, holding process development, piloting, engineering, commercial scale-up and product roll-out responsibilities as part of the Primobius GmbH joint venture.

-

-

-